OBJECTIVE: We examined the association between body mass index (BMI) around the time of diagnosis, weight change post-diagnosis, and breast cancer prognosis in a prospective cohort study of 1,692 breast cancer survivors. METHODS: Pre-diagnosis weight, weight at study entry, and height was obtained from mailed questionnaires and then weight change and BMI were calculated. After approximately seven years of follow-up, 207 recurrences, 99 deaths due to breast cancer, and 162 deaths due to any cause were reported. Delayed entry Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), controlling for treatment and known prognostic factors. RESULTS: Being obese one year before diagnosis was associated with an increased risk of death from any cause (HR = 1.6; 95% CI: 1.1-2.3) and a suggestion of increased risk of death from breast cancer (HR = 1.6; 95% CI: 0.9-2.7). However, weight gain up to four years after a breast cancer diagnosis was not associated with an increased risk of recurrence or death from any cause nor did moderate weight loss (5-10%) decrease risk of these outcomes. There was some evidence that women who had larger weight losses (>or=10%) between pre-diagnosis and study entry had an increased risk of recurrence (HR = 1.7; 95% CI 1.0-2.6) and death due to any cause (HR = 2.1; 95% CI 1.3-3.4) compared to being weight stable. This elevated risk was more pronounced among women who were obese before diagnosis (BMI >or= 30 kg/m(2)) or who had ER- or PR- tumors. CONCLUSION: We found that being obese before breast cancer diagnosis was associated with increased risk of recurrence and poorer survival, corroborating results from previous studies. However, weight gain after diagnosis did not confer additional risk. Body weight pre-diagnosis appears to be the strongest predictor of an adverse breast cancer prognosis.
OBJECTIVE: We examined the association between body mass index (BMI) around the time of diagnosis, weight change post-diagnosis, and breast cancer prognosis in a prospective cohort study of 1,692 breast cancer survivors. METHODS: Pre-diagnosis weight, weight at study entry, and height was obtained from mailed questionnaires and then weight change and BMI were calculated. After approximately seven years of follow-up, 207 recurrences, 99 deaths due to breast cancer, and 162 deaths due to any cause were reported. Delayed entry Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), controlling for treatment and known prognostic factors. RESULTS: Being obese one year before diagnosis was associated with an increased risk of death from any cause (HR = 1.6; 95% CI: 1.1-2.3) and a suggestion of increased risk of death from breast cancer (HR = 1.6; 95% CI: 0.9-2.7). However, weight gain up to four years after a breast cancer diagnosis was not associated with an increased risk of recurrence or death from any cause nor did moderate weight loss (5-10%) decrease risk of these outcomes. There was some evidence that women who had larger weight losses (>or=10%) between pre-diagnosis and study entry had an increased risk of recurrence (HR = 1.7; 95% CI 1.0-2.6) and death due to any cause (HR = 2.1; 95% CI 1.3-3.4) compared to being weight stable. This elevated risk was more pronounced among women who were obese before diagnosis (BMI >or= 30 kg/m(2)) or who had ER- or PR- tumors. CONCLUSION: We found that being obese before breast cancer diagnosis was associated with increased risk of recurrence and poorer survival, corroborating results from previous studies. However, weight gain after diagnosis did not confer additional risk. Body weight pre-diagnosis appears to be the strongest predictor of an adverse breast cancer prognosis.
Authors: W Demark-Wahnefried; B L Peterson; E P Winer; L Marks; N Aziz; P K Marcom; K Blackwell; B K Rimer Journal: J Clin Oncol Date: 2001-05-01 Impact factor: 44.544
Authors: Nazmus Saquib; Shirley W Flatt; Loki Natarajan; Cynthia A Thomson; Wayne A Bardwell; Bette Caan; Cheryl L Rock; John P Pierce Journal: Breast Cancer Res Treat Date: 2006-11-23 Impact factor: 4.872
Authors: James J Dignam; Kelly Wieand; Karen A Johnson; Bernard Fisher; Lei Xu; Eleftherios P Mamounas Journal: J Natl Cancer Inst Date: 2003-10-01 Impact factor: 13.506
Authors: Nagi Kumar; Kathryn A Allen; Diane Riccardi; Barry B Bercu; Alan Cantor; Sue Minton; Lodovico Balducci; Paul B Jacobsen Journal: Breast Cancer Res Treat Date: 2004-01 Impact factor: 4.872
Authors: Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake Journal: J Natl Cancer Inst Date: 2013-08-29 Impact factor: 13.506
Authors: Christina M Dieli-Conwright; Frank C Sweeney; Kerry S Courneya; Debu Tripathy; Nathalie Sami; Kyuwan Lee; Thomas A Buchanan; Darcy Spicer; Leslie Bernstein; Joanne E Mortimer; Wendy Demark-Wahnefried Journal: Cancer Date: 2018-11-30 Impact factor: 6.860
Authors: Patrick T Bradshaw; Joseph G Ibrahim; June Stevens; Rebecca Cleveland; Page E Abrahamson; Jessie A Satia; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Epidemiology Date: 2012-03 Impact factor: 4.822
Authors: Shannon M Conroy; Gertraud Maskarinec; Lynne R Wilkens; Kami K White; Brian E Henderson; Laurence N Kolonel Journal: Breast Cancer Res Treat Date: 2011-04-16 Impact factor: 4.872
Authors: Heather Greenlee; Danika L Lew; Dawn L Hershman; Vicky A Newman; Lisa Hansen; Sheri J Hartman; Judith Korner; Zaixing Shi; Christine L Sardo Molmenti; Antoine Sayegh; Lou Fehrenbacher; Shelly Lo; Jennifer Klemp; Kristine Rinn; John M Robertson; Joseph Unger; Julie Gralow; Kathy Albain; Robert Krouse; Carol Fabian Journal: Obesity (Silver Spring) Date: 2018-09-11 Impact factor: 5.002
Authors: Julia A Newton-Bishop; Samantha Beswick; Juliette Randerson-Moor; Yu-Mei Chang; Paul Affleck; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Kairen Kukalizch; Linda Whitaker; Sharon Jackson; Edwina Gerry; Clarissa Nolan; Chandra Bertram; Jerry Marsden; David E Elder; Jennifer H Barrett; D Timothy Bishop Journal: J Clin Oncol Date: 2009-09-21 Impact factor: 44.544
Authors: Avonne E Connor; Richard N Baumgartner; Christina Pinkston; Kathy B Baumgartner Journal: J Womens Health (Larchmt) Date: 2013-03-26 Impact factor: 2.681